Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Microbiol. 2007 Jul;5(7):555-63.

Pathogenic epitopes, heterologous immunity and vaccine design.

Author information

  • 1Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. Raymond.Welsh@umassmed.edu

Abstract

Substantial research has been directed towards the development of a new generation of vaccines that are based on the inclusion of immunogenic epitopes in recombinant vectors. Here we examine the evidence that under certain conditions immunogenic epitopes can do more harm than good and might therefore be considered pathogenic. We suggest that the specific removal of such pathogenic epitopes from vaccines might increase their prophylactic potential, while minimizing the risk of side-effects from vaccine use.

PMID:
17558423
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk